• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Gastrointestinal Endoscopy >Endoscopic hemostasis is rarely used for hematochezia: A population-based study from the Clinical Outcomes Research Initiative National Endoscopic Database
【24h】

Endoscopic hemostasis is rarely used for hematochezia: A population-based study from the Clinical Outcomes Research Initiative National Endoscopic Database

机译：内镜止血很少用于便血：来自临床结果研究计划国家内窥镜数据库的基于人群的研究

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background Data on the use of endoscopic hemostasis performed during colonoscopy for hematochezia are primarily derived from expert opinion and case series from tertiary care settings. Objectives To characterize patients with hematochezia who underwent in-patient colonoscopy and compare those who did and did not receive endoscopic hemostasis. Design Retrospective analysis. Setting Clinical Outcomes Research Initiative National Endoscopic Database, 2002 to 2008. Patients Adults with hematochezia. Interventions None. Main Outcome Measurements Demographics, comorbidities, practice setting, adverse events, and colonoscopy procedural characteristics and findings. Results We identified 3151 persons who underwent in-patient colonoscopy for hematochezia. Endoscopic hemostasis was performed in 144 patients (4.6%). Of those who received endoscopic hemostasis, the majority were male (60.3%), white (83.3%), and older (mean age 70.9 ± 12.3 years); had a low-risk American Society of Anesthesiologists classification (53.9%); and underwent colonoscopy in a community setting (67.4%). The hemostasis-receiving cohort was significantly more likely to be white (83.3% vs 71.0%, P =.02), have more comorbidities (classes 3 and 4, 46.2% vs 36.0%, P =.04), and have the cecum reached (95.8% vs 87.7%, P =.003). Those receiving hemostasis were significantly more likely to have an endoscopic diagnosis of arteriovenous malformations (32.6% vs 2.6%, P =.0001) or a solitary ulcer (8.3% vs 2.1%, P <.0001). Limitations Retrospective database analysis. Conclusions Less than 5% of persons presenting with hematochezia and undergoing inpatient colonoscopy received endoscopic hemostasis. These findings differ from published tertiary care setting data. These data provide new insights into in-patient colonoscopy performed primarily in a community practice setting for patients with hematochezia.
机译：在结肠镜检查期间进行内镜止血治疗时使用内镜止血的背景资料主要来自专家意见和三级医疗机构的病例系列。目的表征接受了结肠镜检查的血便患者，并比较接受和未接受内镜止血的患者。设计回顾分析。制定临床结果研究计划国家内窥镜数据库，2002年至2008年。成年病人。干预措施无。主要结果测量人口统计学，合并症，实践环境，不良事件以及结肠镜检查的程序特征和发现。结果我们确定了3151例因结肠镜检查而接受了结肠镜检查的人。 144例患者（4.6％）进行了内镜止血。在接受内镜止血治疗的患者中，男性占多数（60.3％），白人（83.3％）和年龄较大（平均年龄70.9±12.3岁）;具有低风险的美国麻醉医师学会分类（53.9％）;并在社区进行结肠镜检查（67.4％）。接受止血疗法的人群更可能是白人（83.3％vs 71.0％，P = .02），合并症更多（3级和4级，46.2％vs 36.0％，P = .04），并且有盲肠达到（95.8％对87.7％，P = .003）。接受止血治疗的患者更有可能接受内镜诊断为动静脉畸形（32.6％vs. 2.6％，P = .0001）或孤立性溃疡（8.3％vs 2.1％，P <.0001）。局限性回顾性数据库分析。结论内镜下止血患者中仅有5％出现便血并进行结肠镜检查。这些发现与公布的三级医疗机构数据不同。这些数据为住院结肠镜检查提供了新的见解，主要是在社区实践中为患有便血的患者进行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号